Invited Speaker/Faculty at National and International Medical Meetings
  1. M. El Shahawy, M.D.; “The Effect of Magnesium Deficiency on the Cardiovascular System”, seminar presented at the Physiology Department, Mayo Clinic, Rochester, MN., Mayo Clinic Bulletin., February 12, 1971, No. 7, Vol. 49.
  2. M. El Shahawy, et. al.; “Selected Observations on Hyperthyroid, Magnesium-Deficient Dogs”, presented at the Research Club, Mayo Clinic, Rochester, MN, Mayo Clinic Bulletin, April 23, 1971.
  3. M. El Shahawy, et. al.; "Magnesium Deficiency and the Hyperthyroid Heart" presented at the First International Symposium on Magnesium Deficiency in the Human Pathology in Vittel, France; May 9-19, 1971.
  4. M. El Shahawy, et. al.; "Cardiovascular Effects of Magnesium Deficiency and thyroxin Administration" Presented at the Annual Meeting of A.C.C.P. October 26, 1971.
  5. M. El Shahawy, et. al.; "Increased Plasma Renin Activity and Secondary Aldosteronism in Hyperthyroidism: Augmentation by Magnesium Deficiency" presented at the Annual Meeting of the AHA in Anaheim, California on November 16, 1971.
  6. M. El Shahawy, et. al.; "The Effect of Thyroid Hormone on Intracardiac Conduction with and without Propranolol' presented at the American Heart Association 45th Scientific Sessions, November 16-19, 1972, in Dallas, Texas.
  7. Albert A. Carr, M. El Shahawy, et. al.; "The Effect of Thyroid Hormone and B-Blockade on Renin Release in Hyperthyroid Dogs" presented at the American Heart Association 45th Scientific Sessions, November 16-19, 1972, in Dallas, Texas.
  8. M. Stefadouros, M. El Shahawy, et. al.; "Non-Invasive Study of the Effect of Isometric Exercise on the Size and Performance of the Normal Heart" presented at the American Heart Association 46th Scientific Sessions, November 1973. Atlantic City, New Jersey.
  9. M. El Shahawy, et. al.; "Thyroid Hormones and the Prevention of Heart Block" presented at the First Annual Research Symposium of the Florida Heart Association on January 19, 1974. Tampa, Florida.
  10. M. El Shahawy, et. al.; “Basic Principals of Echocardiography and Instrumentation”, presented at the Non-Invasive Cardiovascular Evaluation. January 24, 1974. University of Florida. Gainesville, Florida
  11. M. El Shahawy, M.D., F.A.C.C.; “Demonstration of Echocardiographic Exam”, presented at the Non-Invasive Cardiovascular Evaluation. January 24, 1974. University of Florida. Gainesville, Florida
  12. M. El Shahawy, M.D., F.A.C.C.; “Echocardiography in the Diagnosis of Valvular Heart Disease”, presented at the Non-Invasive Cardiovascular Evaluation 1974, January 25, 1974. University of Florida. Gainesville, Florida
  13. M. El Shahawy, M.D., F.A.C.C.; "Hypertrophic Obstructive Cardiomyopathy: Management with Beta Blocker, Calcium Channel Blocker, or Surgery?" presented at the 5th Annual, First International Cardiovascular Symposium, jointly sponsored by the University of Florida and the Cardiovascular Institute of Sarasota. Cairo Egypt. November 20-29, 1992.
  14. M. El Shahawy, M.D., F.A.C.C.; "Hypertrophic Cardiomyopathy: Management with Beta Adrenergic Blockers, Calcium Channel Blockers, DDD Permanent Pacing, or Surgery?" presented at the 40th Anniversary Meeting of the American Medical Society of Vienna. March 26, 1993. Vienna, Austria
  15. M. El Shahawy, M.D., F.A.C.C.; "Mitral Valve Prolapse-What is New?' presented at the 7th Annual, 3rd           International Cardiovascular Symposium, jointly sponsored by the University of Florida and the Cardiovascular Institute of Sarasota, held in Athens, Greece and Istanbul, Turkey. October 1-11, 1993.
  16.  M. El Shahawy, M.D., F.A.C.C.; "Cardiomyopathies-Newer Insights" presented at the 7th Annual, 3rd International Cardiovascular Symposium, jointly sponsored by the University of Florida, University of   Vienna (Austria) and the Cardiovascular Institute of Sarasota, held in Vienna, Austria, September 15-27, 1994.
  17.  M. El Shahawy, M.D., F.A.C.C.; "Recent Advances in the Treatment of Hypertrophic Cardiomyopathy” “I.H.S.S”, presented at the 8th Annual, 4th International Cardiovascular Symposium, jointly sponsored by the Cardiovascular Institute of Sarasota and the University of Florida, held in Rome, Italy and Barcelona, Spain, September 26-October 9, 1995.
  18. M. El Shahawy, M.D., F.A.C.C.; "Hypertrophic Cardiomyopathy-Newer Treatment Modalities" presented at the 27th Annual Scientific Symposium of the Hungarian Medical Association of America, October 22-27, 1995 in Sarasota, FL.
  19. M. El Shahawy, M.D., F.A.C.C.; "Prevention of Stroke in Atrial Fibrillation" presented at the XXIII Congress of the Egyptian Society of Cardiology, February 28-March 2, 1996 in Luxor, Egypt.
  20. M. El Shahawy, M.D., F.A.C.C.; "Cardiovascular Complications of Diabetes Mellitus" presented at the Annual Meeting of Diabetic: Nurses, May 15-19, 1996 in Longboat Key, FL
  21.  M. El Shahawy, M.D., F.A.C.C.; "Cardio embolic Stroke Prevention" presented at the 9th Annual, 5th International Cardiovascular Symposium, jointly sponsored by the Cardiovascular Institute of Sarasota       Foundation, Doctors Hospital of Sarasota, and the Cardiovascular Division of the University of Florida,        held in London, England, Scandinavia, and St. Petersburg, Russia, August 20-September 4, 1996.
  22.  M. El Shahawy, M.D., F.A.C.C.; "Atrial Fibrillation: New Standard of Care" presented at the 28th Annual Scientific Symposium of the Hungarian Medical Association of America, Inc., October 27-November 1, 1996. Sarasota, FL.
  23.  M. El Shahawy, M.D., F.A.C.C.; "Atrial Fibrillation: Review of Multi-Center Anticoagulation Studies" presented at the 1st International Symposium on Cardiac Arrhythmia on February 23, 1997. Cairo, Egypt. Jointly sponsored by the Egyptian Society of Cardiology and the North American Society of Pacing and Electrophysiology (NASPE)
  24.  M. El Shahawy, M.D., F.A.C.C.; "Cardio-embolic Stroke" presented at the Egyptian Society of Cardiology 24th Annual Meeting. Cairo, Egypt. February 24-28, 1997.
  25.  M. El Shahawy, M.D., F.A.C.C.; "Updates on Calcium Channel Blockers for the Treatment of Hypertension and Angina Pectoris. Presented to Pinehurst Medical Group. Pinehurst, North Carolina. September 16, 1997. Pinehurst Country Club and Resorts.
  26.  M. El Shahawy, M.D., M.S., F.E.S.C., F.A.C.C.; "Selective T-Channel Blockade for the Treatment of    Hypertension and Angina Pectoris in 1997 (A New Cardiovascular Era)" Presented at the 10th Annual,   International Cardiovascular Symposium sponsored by the Cardiovascular Institute of Sarasota Foundation, Doctors Hospital of Sarasota, and the Cardiovascular Division of the University of Florida, held in Paris, France and Cape Town, South Africa, November 2 l-December 4, 1997.
  27. M. El Shahawy, M.D., M.S., F.E.S.C., F.A.C.C.; "Diabetic Cardiomyopathy" presented at the 10th Annual, 6th International Cardiovascular Symposium sponsored by the Cardiovascular Institute of Sarasota Foundation, Doctors Hospital of Sarasota, and the Cardiovascular Division of the University of Florida, held in Paris, France and Cape Town, South Africa, November 21-December 4, 1997
  28. M. El Shahawy, M.D., M.S., F.E.S.C., F.A.C.C.; "Atrial Fibrillation: Multicenter Trials-Have the Mega trials Answered all the Questions?"presented at the 25th Anniversary Egyptian Society of Cardiology, February 22-27, 1998 in Cairo, Egypt
  29. M. El Shahawy, M.D., M.S., F.E.S.C., F.A.C.C.; "Heart Failure Current and future Treatment" presented at the 25th Anniversary Egyptian Society of Cardiology on February 22-27, 1998 in Cairo, Egypt.
  30. M. El Shahawy, M.D., M.S., F.E.S.C., F.A.C.C.; ''Update on Calcium Channel Blockers for the Treatment of Hypertension and Angina Pectoris" presented at the International Symposium co Heart Disease, "From Molecules to Patient Care", sponsored by the International Society and Federation of Cardiology and the International Academy of Cardiovascular Sciences, May 19-21, 1998 in Cairo, Egypt.
  31. M. El Shahawy, M.D., M.S., F.E.S.C., F.A.C.C.; "Diabetic Heart Disease, Update 1998" presented at the 11th Annual, 7th International Cardiovascular Symposium on October 12, 1998 in China.
  32. M. El Shahawy, M.D., M.S., F.E.S.C., F.A.C.C.; "Recent Advances & Strategies for Hypertension Control" presented at the 11th Annual, 7th International Cardiovascular Symposium, jointly sponsored by the Cardiovascular Institute of Sarasota Foundation, Doctors Hospital of Sarasota, and the Cardiovascular        Division of the University of Florida, on October 17, 1998 in China.
  33. M. El Shahawy, M.D., M.S., F.E.S.C., F.A.C.C.; “A, B, C, D, Treatment of Heart Failure” presented at the 26th Annual Meeting of the Egyptian Society of Cardiology in Cairo-Egypt, February 14 - 19, 1999
  34. M. El Shahawy, M.D., M.S., F.E.S.C., F.A.C.C.; “Diabetic Heart Disease Update 1999” presented at The 12th Annual 8th International Cardiovascular Symposium in South America from Santiago, Chile to Buenos Aires, Argentina, November 19 - December 7, 1999
  35. M. El Shahawy, M.D., M.S., F.E.S.C., F.A.C.C.; “Hypertension Update JNC VI” presented at The 12th Annual 8th International Cardiovascular Symposium in South America from Santiago, Chile to Buenos Aires, Argentina, November 19 – December 7, 1999    
  36. M. El Shahawy, M.D., M.S., F.E.S.C., F.A.C.C.; “Atrial Fibrillation and Stroke Prevention In Diabetic Patients, presented at the 31st Annual Scientific Symposium Hungarian Medical Association of America October 24 – 29, 1999, Sarasota, Florida
  37. M. El Shahawy, M.D., M.S., F.E.S.C., F.A.C.C.; “Diabetic Heart Disease Update 2000” presented at the 27th Annual Congress of The Egyptian Society of Cardiology, February 21st – 25th, 2000, Cairo, Egypt  
  38. M. El Shahawy, M.D., M.S., F.E.S.C., F.A.C.C.; Lecture Of The Year: “Hypertension Update JNC (VI) Current Management” presented at the 27th Annual Congress of The Egyptian Society of Cardiology, February 21st – 25th, 2000, Cairo, Egypt
  39. M. El Shahawy, M.D., M.S., F.E.S.C., F.A.C.C.; “Stroke Prevention in Atrial Fibrillation” presented at the  27th Annual Congress of The Egyptian Society of Cardiology, February 21st – 25th, 2000, Cairo, Egypt
  40. M. El Shahawy, M.D., M.S., F.E.S.C., F.A.C.C.; “Heart Failure Update: Current and Future Management”, presented at the 13th Annual 9thInternational Cardiovascular Symposium, October 12th – 28th, 2000, Australia and New Zealand
  41. M. El Shahawy, et. al.; “The Latest Information in the Diagnosis and Management of Hypertension”  presented at the 13th Annual 9thInternational Cardiovascular Symposium, October 12th – 28th, 2000, Australia and New Zealand
  42. M. El Shahawy, M.D., M.S., F.E.S.C., F.A.C.C.; “Stroke Prevention in Atrial Fibrillation: What Have We Learned from the Mega trials”, presented at the 13th Annual 9th International Cardiovascular Symposium, October 12th – 28th, 2000, Australia and New Zealand…
  43. M. El Shahawy, M.D., M.S., F.E.S.C., F.A.C.C.; "Atrial Fibrillation: Have The Mega Trials Answered All The Questions" presented at the 50thGolden Jubilee Congress of the Egyptian Society of Cardiology, February 19-23, 2001.
  44. M. El Shahawy, M.D., M.S., F.E.S.C., F.A.C.C.; "Diabetic Heart Disease Update 2001" presented at the 50th Golden Jubilee Congress of the Egyptian Society of Cardiology, February 19-23, 2001.
  45.  M. El Shahawy, M.D., M.S., F.E.S.C., F.A.C.C.; “Diabetic Heart Disease: Current Medical Management”, presented at the 14th Annual 10thInternational Cardiovascular Symposium, October 16th – 28th, 2001. Caribbean Island.
  46.  M. El Shahawy, M.D., M.S., F.E.S.C., F.A.C.C.: “Current Management of Acute Heart Failure” presented at the 14th Annual 10th International Cardiovascular Symposium, October 16th – 28th, 2001. Caribbean Island.
  47.  M. El Shahawy, M.D., M.S., F.E.S.C., F.A.C.C.: “Current Treatment of Acute Heart Failure”, presented at the 29th International Conference of the Egyptian Society of Cardiology, February 4-8, 2002. Alexandria, Egypt.
  48.  M. El Shahawy, M.D., M.S., F.E.S.C., F.A.C.C.: “New Treatment of High Risk Cardiovascular Patients ”Hope and Micro Hope Trials”, presented at the Nephrology and Hypertension Society of Puerto Rico Annual Meeting, February 23, 2002. San Juan, Puerto Rico.
  49.  M. El Shahawy, M.D., M.S., F.E.S.C., F.A.C.C.: “Diabetes and Cardiovascular Disease”, presented at the Family Physicians Academy of Puerto Rico, March 23, 2002- San Juan, Puerto Rico.
  50.  M. El Shahawy, M.D., M.S., F.E.S.C., F.A.C.C.: “Aggressive Management of Cardiovascular Risk Factors”, presented at the Florida Academy of Family Physicians Annual Meeting, Sponsored by Foundation for Better Health Care, April 19, 2002, Ft. Lauderdale, Florida.
  51.  M. El Shahawy, M.D., M.S., F.E.S.C., F.A.C.C.: “Cardiovascular Risk Reduction in High Risk Patients with A.C.E.I.:  Emphasis on Diabetics with the “H.O.P.E. and Micro H.O.P.E. to Redefine Therapy. Part I presented at the 15th Annual 11th International Cardiovascular Symposium, August 1st-15th, 2002, British Isles.
  52. M. El Shahawy, M.D., M.S., F.E.S.C., F.A.C.C.: “Cardiovascular Risk Reduction in High Risk Patients with A.C.E.I.:  Emphasis on Diabetics with the “H.O.P.E. and Micro H.O.P.E. to Redefine Therapy. Part II presented at the 15th Annual 11th International Cardiovascular Symposium, August 1st-15th, 2002, British Isles.
  53. M. El Shahawy, M.D., M.S., F.E.S.C., F.A.C.C.: ”Dysmetabolic Cardiac Syndrome” presented at the 4th Annual New Year Symposium of the Association of American Black Cardiologists “ABC”, Western Caribbean, December 28, 2002- January 4, 2003
  54.  M. El Shahawy, M.D., M.S., F.E.S.C., F.A.C.C.: ”Chronic Stable Angina Pectoris: Current Diagnosis and Management”- Panel Meeting – Sunday March 30, 2003 at the 52nd Annual Scientific Session American College of Cardiology, March 30 – April 2, 2003, Chicago, Illinois.
  55.  M. El Shahawy, M.D., M.S., F.E.S.C., F.A.C.C.:  “The Dysmetabolic Cardiac Syndrome” presented at the 16th Annual, 12th International Cardiovascular Symposium, October 24th –November 7, 2003, Spain and Portugal.
  56.  M. El Shahawy, M.D., M.S., F.E.S.C., F.A.C.C.: “Peripheral Arterial Disease in Diabetic:  Current Diagnosis and Management” Presented at the 16th Annual, 12th International Cardiovascular Symposium, October 24th –November 7, 2003, Spain and Portugal.
  57.  M. El Shahawy, M.D., M.S., F.E.S.C., F.A.C.C.:  “Dysmetabolic Syndrome” Presented at the 17th Annual, 13th International Cardiovascular Symposium, July 17th –July 29th, 2004, Austria, Slovenia and Italy.
  58.  M. El Shahawy, M.D., M.S., F.E.S.C., F.A.C.C.: “What is Metabolic Syndrome? How Does One Diagnose This? Local or Global?- Panel Meeting – Tuesday, March 9, 2004 at the 53rd Annual Scientific Session American College of Cardiology, March 7 – March 10, 2004, New Orleans, Louisiana.
  59.  M. El Shahawy, M.D., M.S., F.E.S.C., F.A.C.C.: “Metabolic Syndrome Current Diagnosis and Management”, Presented at the 18th Annual, 14thInternational Cardiovascular Symposium, Nov 29th to Dec. 12th, 2005, Republic of Seychells, Madagascar, Mauritius and Cape Town(South Africa).
  60.  M. El Shahawy, M.D., M.S., F.E.S.C., F.A.C.C.: “The Cardio Metabolic Syndrome: Current Diagnosis and Management 2006”, Presented at the 19th Annual, 15th International Cardiovascular Symposium, October 13-25 2006, ITALY, EGYPT   GREECE, And Turkey.
  61.  M. El Shahawy, M.D., M.S., F.E.S.C., F.A.C.C.; F.A.H.ACardiovascular Continuum Update 2007Presented at the 3rd Annual,  Cardiovascular Symposium, jointly sponsored by the Cardiovascular Institute of Sarasota, Sarasota Memorial Hospital health care Foundation, Sarasota Memorial Hospital of Sarasota and the cardiovascular division of the University of South Florida. March 2007
  62.  M. El Shahawy, M.D., M.S., F.E.S.C., F.A.C.C.; F.A.H.A: Peripheral Arterial Disease as Major Clue for Cardiovascular Disease. Presented at the 3ed Annual, Cardiovascular Symposium, jointly sponsored by the Cardiovascular Institute of Sarasota, Sarasota memorial hospital health care Foundation, Sarasota Memorial Hospital of Sarasota and the cardiovascular division of the University of South Florida. March 2007.
  63.  M. El Shahawy, M.D., M.S., F.E.S.C., F.A.C.C.; F.A.H.A: AcuteCoronary Syndrome. Presented at AHA sponsored international Symposium on BLS/ACLS/ Instructor Course in New Delhi, India at Max Health Care Institution from October 18-26th 2007.
  64.  M. El Shahawy, M.D., M.S., F.E.S.C., F.A.C.C.; F.A.H.A: STROKE. Presented at AHA sponsored International Symposium on BLS/ACLS/ Instructor Course in New Delhi, India at Max Health Care Institution from October 18-26th 2007.
  65. M. El Shahawy, M.D., M.S., F.E.S.C., F.A.C.C.; F.A.H.A: Tachycardia, Stable and Unstable. Presented at AHA sponsored international Symposium on BLS/ACLS/ Instructor Course in New Delhi, India at Max Health Care Institution from October 18-26th 2007.
  66. M. El Shahawy, M.D., M.S., F.E.S.C., F.A.C.C.; F.A.H.A:  Pulseless VT/VF Presented at AHA sponsored International Symposium on BLS/ACLS/ Instructor Course in New Delhi, India at Max Health Care Institution, October 18-26th 2007.
  67. M. El Shahawy, M.D., M.S., F.E.S.C., F.A.C.C.; F.A.H.APeripheral Arterial Disease as a Clue to Cardiovascular and Cerebrovascular Disease”, Presented at the 20th Annual, 16th International Cardiovascular Symposium, in India’s Golden Triangle October 22nd November 2nd 2007
  68. M. El Shahawy, M.D., M.S., F.E.S.C., F.A.C.C.; F.A.H.A: Cardiovascular Disease prevention center. When? Where? and What? Presented at the 4th Annual, Cardiovascular Symposium, jointly sponsored by the Cardiovascular Institute of Sarasota, Sarasota Memorial Hospital health care Foundation, Sarasota Memorial Hospital of Sarasota and the Cardiovascular Division of the University of South Florida,  February 9th, 2008
  69. M. El Shahawy, M.D., M.S., F.E.S.C., F.A.C.C.; F.A.H.A: “Immune Modulation of Atherosclerosis” presented   at the 35th Annual Congress of The Egyptian Society of Cardiology, February 25th – 29th, 2008, Cairo, Egypt
  70. M. El Shahawy, M.D., M.S., F.E.S.C., F.A.C.C.; F.A.H.A: “Obesity and Thrombosis” presented at the 35th Annual Congress of The Egyptian Society of Cardiology, February 25th – 29th, 2008, Cairo, Egypt.
  71. M. El Shahawy, M.D., M.S., F.E.S.C., F.A.C.C.; F.A.H.A “Cardiovascular Risk Factors Assessment: Overview  2008” ”, Presented at the 21st Annual, 17th  International Cardiovascular Symposium, in Romania and Turkey, sponsored  by CVIS and The University of South Florida  August 24 to 28/2008
  72. M. El Shahawy, MD, MS, FESC, FACC,FAHA: “Cardio Metabolic Syndrome: Update ’08”, Presented  at the 21st Annual, 17th  International Cardiovascular Symposium, in Romania and Turkey, sponsored  by  CVIS and The University of South Florida August 24 to 28/2008
  73. M. El Shahawy, MD, MS, FESC, FACC,FAHA: “Global Cardiovascular Risk Factors: Update 2009., Presented at  the 5th Annual, Cardiovascular Symposium, jointly sponsored by the Cardiovascular Institute of Sarasota, Sarasota  Memorial Hospital Healthcare Foundation, Sarasota Memorial Hospital of Sarasota and the cardiovascular division of the University of South Florida, February 7th, 2009
  74. M. El Shahawy, MD, MS, FESC, FACC,FAHA: “The Metabolic Syndrome as a major Killer”, Presented at the 5th Annual, Cardiovascular Symposium, jointly sponsored by the Cardiovascular Institute of Sarasota, Sarasota Memorial Hospital Healthcare Foundation, Sarasota Memorial Hospital and the Cardiovascular Division of the University of South Florida, February 7th, 2009.   
  75. M. El Shahawy, MD, MS, FESC, FACC,FAHA: “The Value of Coronary Calcium Scoring by CCT In   the Diagnosis And Prevention of Coronary Artery Disease” Presented at the 22nd Annual, 18th International Cardiovascular Symposium, in Switzerland and Germany, September 4th to 14th 2009 sponsored by CVIS and The University of South Florida
  76. M. El Shahawy, MD, MS, FESC, FACC,FAHA: “Cardiac CT: Answers to questions you might have been afraid to ask” Presented at the 22nd Annual, 18th International Cardiovascular Symposium, in Switzerland and Germany, September 4th to 14th 2009 sponsored by CVIS and The University of South Florida .
  77. M. El Shahawy, MD, MS, FESC, FACC,FAHA, FSCCT: “The Cardio metabolic Syndrome as major killer: Update 2010. Presented at the 6thAnnual, Cardiovascular Symposium, jointly sponsored by the Cardiovascular Institute of Sarasota, Sarasota Memorial Hospital health care Foundation, Sarasota Memorial Hospital of Sarasota and the Cardiovascular Division of the University of South Florida, February 6th 2010.
  78. M.El Shahawy, MD, MS, FESC, FACC,FAHA, FSCC, FSCCT:“SMH, Cardiovascular Disease Assessment Center. What have we accomplished? Presented at the 6th Annual, Cardiovascular Symposium,  jointly sponsored by the Cardiovascular Institute of Sarasota, Sarasota memorial hospital health care Foundation, Sarasota Memorial Hospital of Sarasota and the cardiovascular division of the University of South Florida,February 6th 2010.
  79. M. El Shahawy, MD, MS, FESC, FACC,FAHA, FSCC, FSCCT: “ New Cardiovascular Disease Risk Scoring System  Beyond Framingham” presented at the 37th Annual Congress of The Egyptian Society of Cardiology, February 23 to 25, 2010, Cairo, Egypt,
  80. M. El Shahawy, MD, MS, FESC, FACC, FAHA, FSCC, FSCCT: “Rise  In Systolic Blood Pressure Over 30mmHg After Mild Exercise As A  New Marker For  Early Cardiovascular Disease Risk Stratification in Asymptomatic Normotensive Patients Regardless of sex presented at the 37thAnnual Congress of The Egyptian Society of Cardiology, February 23 to 25, 2010, Cairo, Egypt.
  81. M. El Shahawy, MD, MS, FESC, FACC,FAHA, FSCC, FSCCT: “Time to Mandate a More Accurate tool to Assess CVD risk in Women beyond Framingham” presented at the 37th Annual Congress of The Egyptian Society of Cardiology, February 23 to 25, 2010, Cairo, Egypt
  82. M. El Shahawy, MD, MS, FESC, FACC,FAHA, FSCC, FSCCT, FASH: “CARDIAC CTA: Answers To Questions You Might Have Been Afraid To Ask About Radiation”, Presented at Level 2 Course Certification   Sponsored by The University of Arizona, held at the Institute for Advanced Medicine in Sarasota Florida,  May 21-23, 2010.
  83. M. El Shahawy, MD, MS, FESC, FACC, FAHA, FSCC, FSCCT, FASH: “Calcium Scanning and Scoring. What it all means?  Presented at Level 2 Course Certification Sponsored By the University Of Arizona, held at the Institute For Advanced Medicine in  Sarasota  Florida, May 21-23, 2010.
  84. M. El Shahawy, MD, MS, FESC, FACC, FAHA, FSCC, FSCCT, FASH: “Cardiovascular Disease Risk Assessment  Beyond Framingham: Update 2011” Presented at the 7th Annual, Cardiovascular Symposium,  jointly sponsored by the Cardiovascular Institute of Sarasota, Sarasota Memorial Hospital Healthcare Foundation, Sarasota Memorial Hospital and the Cardiovascular Division of the University of South Florida,February 4th 2011.
  85. M. El Shahawy, MD, MS, FESC, FACC, FAHA, FSCC, FSCCT, FASH: “One Ounce of Prevention Better than  One Pound of Cure” Presented at the 7th Annual, Cardiovascular Symposium,   jointly sponsored by the Cardiovascular Institute of Sarasota, Sarasota Memorial Hospital Healthcare Foundation, Sarasota Memorial Hospital and the Cardiovascular Division of the University of  South Florida,February 5th 2011.
  86. M. El Shahawy, MD, MS, FESC, FACC, FAHA, FSCC, FSCCT, FASH: “Global Cardiovascular Risk Factors: Update 2011” Presented at the 24th Annual, 20th International Cardiovascular Symposium, in Cape Town, South Africa, July 21st  to 28th 2011 jointly sponsored by the Cardiovascular Institute of Sarasota, Sarasota Memorial Hospital Healthcare Foundation, Sarasota Memorial Hospital and the Cardiovascular Division of the University of South Florida
  87. M. El Shahawy, MD, MS, FESC, FACC, FAHA, FSCC, FSCCT, FASH: “Cardiac CT update 2011” Presented at the 24th  Annual, 20thInternational Cardiovascular Symposium, in Cape Town, South Africa, July 21st  to 28th  2011 jointly sponsored by the Cardiovascular Institute of Sarasota, Sarasota Memorial Hospital Healthcare Foundation, Sarasota Memorial Hospital and the Cardiovascular Division of the University of  South Florida
  88. M. El Shahawy, MD, MS, FESC, FACC, FAHA, FSCC, FSCCT, FASH: “Novel approach for cardiovascular Disease risk Assessment in 2011”,  presented at the 38th Annual Congress of The  Egyptian Society of Cardiology, October 18 to 22, 2011, Sharm El-Sheikh - Egypt  
  89. M. El Shahawy, MD, MS, FESC, FACC, FAHA, FSCC, FSCCT, FASH: “Stroke Prevention in Atrial Fibrillation: Update 2011”,  presented at the 38th Annual Congress of The  Egyptian Society of Cardiology, October 18 to 22, 2011, Sharm El-Sheikh - Egypt
  90. M. El Shahawy, MD, MS, FESC, FACC, FAHA, FSCC, FSCCT, FASH: “ Carotid Intima Media Thickness (CIMT)   Measurement for Cardiovascular Disease  Risk Stratification in Newly Diagnosed Asymptomatic  Hypertensive Subjects”, presented at the 39th Annual Congress of The  Egyptian Society of Cardiology, February 28th, 2012, Cairo, Egypt
  91. M. El Shahawy, MD, MS, FESC, FACC, FAHA, FSCC, FSCCT, FASH:”Obesity is a disease even in asymptomatic normotensive  subjects: what is the evidence and why?”, presented at the 15th Meeting of the Egyptian Hypertension Society, April 11-12,  2012, Cairo, Egypt
  92. M. El Shahawy, MD, MS, FESC, FACC, FAHA, FSCC, FSCCT, FASH: “Perivascular Adipose Tissue: More Than a Scaffold”, presented at the  World Congress of Cardiology, April 18 - 21st, 2012 ,  Dubai, United Arab Emirates
  93. M. El Shahawy, MD, MS, FESC, FACC, FAHA, FSCC, FSCCT, FASH: “Novel Approach for Cardiovascular Disease Risk Assessment: beyond Framingham” presented at the Slovenian Society of Cardiology 20th Annual Meeting, May 12, 2012, Radenci, Slovenia
  94. M. El Shahawy, MD, MS, FESC, FACC, FAHA, FSCC, FSCCT, FASH: “ The Cardio metabolic Syndrome”,  Presented at the 25th  Annual, 21stInternational Cardiovascular Symposium, England and Norway,  June 22 to July 6, 2012,  jointly sponsored by the Cardiovascular Disease Assessment Center, The Cardiovascular Center of Sarasota, CVIS Foundation For Education And Research, and Sarasota Memorial Healthcare Foundation      
  95. M. El Shahawy, MD, MS, FESC, FACC, FAHA, FSCC, FSCCT, FASH: “Novel Anticoagulant for Stroke Prevention in Atrial Fibrillation”, Presented at the 25th  Annual, 21st International Cardiovascular Symposium, England and Norway,  June 22 to July 6, 2012,  jointly sponsored by the Cardiovascular Disease Assessment Center, The Cardiovascular Center of Sarasota, CVIS Foundation For Education And Research, and Sarasota Memorial Healthcare  Foundation             
  96. M. El Shahawy, MD, MS, FESC, FACC, FAHA, FSCC, FSCCT, FASH: Oral Presentation Pre-Hypertension is   a   Disease Associated with Significant Structural and Functional Cardiovascular Abnormalities. It is Time to Lower the Bar”, presented at the American Heart Association High Blood Pressure Research 2012 Scientific Sessions, September 22, 2012, in Washington, DC
  97. M. El Shahawy, MD, MS, FESC, FACC, FAHA, FSCC, FSCCT, FASH:  “Perivascular Adipose Tissue As Major Cardiovascular Risk Factor: It Is More Than a Scaffold”, presented at the  9th Congress of the Croatian Cardiac Society, October 13  - 16, 2012,  Opatia, Croatia
  98. M. El Shahawy, MD, MS, FESC, FACC, FAHA, FSCC, FSCCT, FASH:  “>>>>>>>>>>>”, presented at the  9th Congress of the Croatian Cardiac Society, October 13  - 16, 2012,  Opatia, Croatia